Skip to main content
OpenTrials

Clinical trial condition

Esophageal Adenocarcinoma

Explore clinical trials studying Esophageal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

93 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Adenocarcinoma trial results

Recruiting

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

NCT07432295

Conditions
Adenocarcinoma Of Esophagus, Advanced Cancer, Digestive System Diseases, +16 more
Locations
  • I-Mab Site 1016 Goodyear, Arizona, United States
  • I-MAB Site 1005 Duarte, California, United States
  • I-Mab Site 1002 Boston, Massachusetts, United States
  • I-Mab Site 2001 Beijing, China
View Trial Details
Recruiting

Obeticholic Acid for Prevention in Barrett's Esophagus

NCT04939051

Conditions
Adenocarcinoma Of Esophagus, Barrett Esophagus, Digestive System Diseases, +5 more
Locations
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

NCT04900818

Conditions
Adenocarcinoma Of Esophagus, Advanced Cancer, Biliary Tract Cancer (BTC), +20 more
Locations
  • Stern Center for Cancer Clinical Trials and Research Orange, California, United States
  • UCHealth Cancer Care - Anschutz Medical Campus Aurora, Colorado, United States
  • Horizon Oncology Research, LLC. Layfayette, Indiana, United States
  • Mass General Hospital Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Recruiting

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

NCT06005493

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Research Site Jacksonville, Florida, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site New York, United States
  • Research Site Beijing, China
View all 25 locations
View Trial Details
Recruiting

A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

NCT06523374

Conditions
Adenocarcinoma Of Esophagus, Barrett Esophagus, Barrett's Esophagus, +11 more
Locations
  • University Hospital Antwerp Edegem, Antwerpen, Belgium
  • Sint-Augustinus Hospital (ZAS) Wilrijk, Antwerpen, Belgium
  • UZ Gent Ghent, Belgium
  • AZ Delta Roeselare, Belgium
View Trial Details
Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

NCT07182149

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Normunity Investigational Site Denver, Colorado, United States
  • Normunity Investigational Site New Haven, Connecticut, United States
  • Normunity Investigational Site Minneapolis, Minnesota, United States
  • Normunity Investigational Site Maumee, Ohio, United States
View Trial Details
Recruiting

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

NCT06623396

Conditions
Abdominal Neoplasms, Adenocarcinoma Of Esophagus, Breast Diseases, +20 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details

Related conditions